United States · Series B startup

Who invested in Neurotech

One round we have observed, with the 12 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

IT Services

Funding summaryUpdated 26 Oct 2026

$35Mraised across 1 round since 2006, from 1 source

Latest round
Series B, $35MNov 2006
Investors
12
See who backed them

The rounds

  1. Nov 2006

Everyone who backed them

Atlas VentureVC firm1round
Versant VenturesVC firm1round
SV Life SciencesVC firm1round
Omega FundsVC firm1round
Apax PartnersPrivate equity1round
Burrill & CompanyVC firm1round
Merlin BiosciencesGrowth equity1round
Alpha AssociatesPrivate equity1round
AVIDA GroupGrowth equity1round
MayflowerVC firm1round
Pound Capitalno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Neurotech as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

LabXVenture studioPer its own site

Quick answers about Neurotech

Who invested in Neurotech?

Neurotech's investors include Atlas Venture, Versant Ventures, SV Life Sciences, Omega Funds and Apax Partners, and 7 more on record.

How much has Neurotech raised?

Neurotech has raised $35M across 1 round since 2006.

When did Neurotech last raise?

Neurotech's most recent round was a Series B of $35M in Nov 2006.

What was Neurotech's biggest round?

Its most recent round, $35M in Nov 2006, is also its largest on record.

Who backed Neurotech first?

Neurotech's first round on record, in Nov 2006, was backed by Atlas Venture, Versant Ventures and SV Life Sciences and 9 others.

What stage is Neurotech at?

Neurotech's latest named round is a Series B, in Nov 2006.

Where is Neurotech based?

Neurotech is based in the United States.

Companies like Neurotech

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.